Conversely, dysregulation of PP1 activity can lead to aberrant activation of Wnt/β-catenin signaling and the PI3K/AKT/mTOR, MAPK, and AMPK pathways, and eventually promotes tumor growth and progression. Here, AKT1 is linked to neoplasm.